SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Dipna Pharmachem Ltd

BSE: 543594 NSE: ISIN: INE0MC401013
  |   Sector:  Miscellaneous   |   Industry:  Trading

Snapshot

Q.1 Which industry/sub-sector does Dipna Pharmachem Ltd belong to?
Dipna Pharmachem Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.2 Is Dipna Pharmachem Ltd a good quality company?
Dipna Pharmachem Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Dipna Pharmachem Ltd undervalued or overvalued?
Dipna Pharmachem Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Dipna Pharmachem Ltd a good buy now?
Dipna Pharmachem Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd revenue growth is -24% for FY-2025 , which is below its 5 year CAGR of 32.5% , indicating slower growth.
Q.2 Gross Profit margin of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd Gross profit margin which is the profit after deduction of direct costs, is 1.2% for FY-2025 , which is in line with its 5 year median of 1.2% , indicating stable margins.
Q.3 Operating Profit Margin of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 3.14% for FY-2025 , which is above its 5 year median of 2.4% indicating increasing margins.
Q.4 Net Profit Margin of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd Net Profit Margin is 0.78% for FY-2025 , is in line with with its 5 year median of 0.78%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 1.2 1.2
Operating Profit Margin 3.14 2.4
Net Profit Margin 0.78 0.78
Q.5 Return on Asset of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd Return on Asset is 0.73(x), which is below its 5 year historical median of 1.03(x), indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd Return on equity is 2.56% for FY-2025 , which is below its historical median of 4.32%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd Return on capital employed is 6.95% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd Cash conversion cycle is -41 , below its historical median of 47 , indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.94 1.56
ROE 2.56 4.32
ROCE 6.95 7.18
Cash Conversion Cycle -41 47
Q.9 Debt to Equity ratio of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd Debt-to-Equity ratio is 0.45 , which is above with the industry average of 0.03 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Dipna Pharmachem Ltd?
Dipna Pharmachem Ltd Debt to cash flow from operations is -1.87 , which is at a unhealthy level, indicating the business is not able to service its debt comfortably.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Dipna Pharmachem Ltd?
Promoters hold 9.98% of the Dipna Pharmachem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Dipna Pharmachem Ltd vs industry peers?
Dipna Pharmachem Ltd revenue CAGR is 32.54% , compared to the industry median CAGR of 0% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 124.9 13.3
Gross Profit 1.5 0.4
Operating Profit 3.9 0
Net Profit 1 0.3
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.94 0.5
ROE 2.56 2.03
ROCE 6.95 3.6
Cash Conversion Cycle -40.78 41

Valuation & price assessment

Q.1 Stock return of Dipna Pharmachem Ltd over the last decade?
Over the last 9 years, the stock has delivered a CAGR of 0% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - -10.5% -42.7%
Q.3 Valuation ratios of Dipna Pharmachem Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 25.45 31.34 21.75
Price to Book 0.6 0.77 1.55
Price to Sales 0.2 0.29 1.87
EV to EBITDA 10.58 15.45 13.67

Check more companies

1. Aditya Infotech
2. Aegis Logistics
3. Redington
4. RRP Semiconductor
5. Honasa Consumer
6. Cello World
7. Lloyds Enterprises
8. MMTC
9. Jeena Sikho Life
10. SG Mart
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×